Title Credit Activity type Target audience Start and expiration dates
The Role of PCSK9 Inhibitors in Lowering LDL-C and Reducing Cardiovascular Risk in Patients with Dyslipidemia
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
Webcast 10/11/2017 to 10/10/2018
Optimizing Patient Outcomes in the Era of PCSK9 Inhibitor Therapeutics
  • 2.00 AMA PRA Category 1 Credit(s)™ credits
  • 2.00 Non-physician credits
Webcast 06/29/2017 to 06/28/2018
Developing Optimized Treatment Plans for Patients with Dyslipidemia in the Era of PCSK9 Inhibitor Therapeutics
  • 2.00 AMA PRA Category 1 Credit(s)™ credits
  • 2.00 Non-physician credits
Webcast 05/30/2017 to 05/29/2018
ACC 2017: A Therapeutic Update to Reduce Risk and Optimize Outcomes for Patients with Reduced or Preserved Ejection Fraction Heart Failure
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
Webcast 05/10/2017 to 05/09/2018
An Update of Emerging Therapeutics to Prevent Stroke in Patients with Non-Valvular Atrial Fibrillation
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
Medical Meeting Report 02/09/2017 to 02/08/2018
AHA 2016: Advances in the Management of Patients with Heart Failure
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
Medical Meeting Report 01/20/2017 to 01/19/2018
AHA 2016: Update on Lipid Lowering Therapies
  • 1.00 AMA PRA Category 1 Credit(s)™ credit
  • 1.00 Non-physician credit
Medical Meeting Report 01/17/2017 to 01/16/2018
ESC 2016: Applying Novel Therapeutics to Improve Outcomes in Patients with Pulmonary Arterial Hypertension
  • 0.50 AMA PRA Category 1 Credit(s)™ credits
  • 0.50 Non-physician credits
Medical Meeting Report 12/29/2016 to 12/28/2017